Freyr Solutions China provides end-to-end regulatory services for medicinal products, helping pharmaceutical companies navigate China's complex regulatory landscape and achieve successful approvals from the National Medical Products Administration (NMPA). The company offers comprehensive support for regulatory strategy, product registration, clinical trial applications, eCTD publishing, regulatory submissions, local representation, and lifecycle management.